MDL Judge Finds Tylenol Autism, ADHD Lawsuits Against J&J Are Not Preempted
The federal judge presiding over all Tylenol autism and ADHD lawsuits has rejected a motion by Johnson & Johnson to have the claims dismissed under federal preemption laws.
The federal judge presiding over all Tylenol autism and ADHD lawsuits has rejected a motion by Johnson & Johnson to have the claims dismissed under federal preemption laws.
A federal judge has invited the FDA to comment on a proposed pregnancy warning for acetaminophen products detailing the risks of autism and ADHD.
Plaintiffs have proposed what Tylenol pregnancy warnings could look like in order to warn expecting mothers about the increased risks of autism and ADHD to their unborn child.
A new CDC study finds that 1-in-36 children in the U.S. have been diagnosed with autism spectrum disorder.
The federal judge presiding over Tylenol autism and ADHD injury claims is requiring plaintiffs to fill out a Plaintiff Fact Sheet which will help with future bellwether trial selections.
Major retailers and Johnson & Johnson now face more than 100 lawsuits over claims ADHD and autism were caused by Tylenol use during pregnancy.
Defendants are asking a federal judge to throw out Tylenol autism and ADHD lawsuits, claiming they are preempted by FDA labeling laws.
A new study warns those with an autism spectrum disorder diagnosis face an increased risk of diabetes and other cardiometabolic illnesses.
A federal judge has issued an order to coordinate discovery proceedings for all Tylenol autism spectrum disorder lawsuits filed in both state and federal courts.
The federal judge presiding over consolidated Tylenol, autism and ADHD lawsuits has called for parties to propose discovery plans which could help lead to the first bellwether trials.